David J Tyrrell

Title: David J Tyrrell: Innovator in Heparin Research

Introduction

David J Tyrrell is a notable inventor based in Alameda, CA (US), recognized for his contributions to the field of biochemistry, particularly in the development of heparin-related therapies. With a total of 3 patents, his work focuses on innovative methods for treating diseases, including cancer.

Latest Patents

Among his latest patents is a method for controlling O-desulfation of heparin, which includes techniques for making and using O-desulfated heparin compositions. These compositions are designed to regulate the degree of desulfation, allowing for variable compositions that can be up to about 99% and 75% desulfated at the 2-O and 3-O positions, respectively. Another significant patent involves sulfated maltooligosaccharides with heparin-like properties, which describes a novel class of highly sulfated maltooligosaccharides that exhibit heparin-like activity. These oligosaccharides are intended for use in treating diseases such as cancer and retinopathies.

Career Highlights

David J Tyrrell is currently associated with Glycomed, Inc., where he continues to advance his research and development efforts in the field of therapeutic agents. His innovative approaches have positioned him as a key figure in the biopharmaceutical industry.

Collaborations

Throughout his career, Tyrrell has collaborated with esteemed colleagues, including Kevin R Holme and Patrick N Shaklee, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

David J Tyrrell's work exemplifies the intersection of innovation and healthcare, particularly in the development of heparin-based therapies. His contributions are significant in the ongoing fight against serious diseases, showcasing the impact of dedicated research and invention.